Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended
This article is from
The Cancer Letter
archive.
Vol. 15 No. 30 | July 28, 1989
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Surveillance Colonoscopy Cost-Effective For High-Risk
July 30, 2010
TCL Archive
Avastin Loses Indication for Breast Cancer
November 18, 2011
TCL Archive
DeVita Defends CHP Awards, Says Program Has High Priority
September 5, 1980
TCL Archive
NCI Sends A Second Letter To Groups About Carboplatin
October 22, 2010
TCL Archive
Schmitt To Chair Senate Health Appropriations Subcommittee
January 2, 1981
TCL Archive
Tobacco Linked To 63 Percent Of Cancer Deaths In Black Men
July 29, 2005